FrieslandCampina secures 2’-FL approval in ANZ, eyes HMO portfolio expansion 31-Oct-2022 By Tingmin Koe FrieslandCampina said its 2’-fucosyllactose trademarked Aequival has been approved by Australia’s and New Zealand’s authorities for use in infant milk formula, and that it is on track in expanding its human milk oligosaccharide (HMO) portfolio.
FrieslandCampina reports challenging first half year for infant formula business in China 25-Sep-2019 By Guan Yu Lim Infant formula brand Friso is facing a challenging first half year in the Chinese market, according to its manufacturer FrieslandCampina.